This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis.
This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis. If changes in BIS parameters correlate with changes in fluid volume and patient symptoms, BIS may help provide a non-invasive way to estimate the amount of fluid to dialyze during a hemodialysis session. Data from this study may be used to inform the design of a future interventional trial of BIS use in hemodialysis patients.
Study Type
OBSERVATIONAL
Enrollment
70
All patients enrolled in this study will undergo BIS measurement before and after 12 hemodialysis sessions (pre-dialysis and post-dialysis BIS measurements for each session). Measurements are not provided to treating physicians and are not used to guide clinical decisions; i.e., BIS measurements are collected for observational purposes only.
Balboa Research - Kearny Mesa
San Diego, California, United States
Balboa Research - Rancho Bernardo
San Diego, California, United States
BIS correlation with amount of fluid dialyzed
BIS-measured fluid change (volume) will be analyzed for correlation with the volume of fluid removed during hemodialysis as documented on dialysis treatment records.
Time frame: 12 hemodialysis sessions (over 4 to 6 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.